MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cencora, Inc. Common Stock (NY:COR)

360.13 +0.16 (+0.04%)
Streaming Delayed Price Updated: 10:56 AM EST, Feb 18, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cencora, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
News headline image
Stocks Rebound, Google Eyes Worst Drop In A Year, Gold Shatters Fresh Records: What's Driving Markets Wednesday? ↗
Wall Street rose on Wednesday, with all major equity indices advancing as investors assessed the latest batch of corporate earnings and drew optimism from positive labor market data. 
Via Benzinga
News headline image
Earnings Scheduled For February 5, 2025 ↗
 
Via Benzinga
News headline image
$100 Invested In Cencora 10 Years Ago Would Be Worth This Much Today ↗
 
Via Benzinga
News headline image
Breaking Down Cencora: 6 Analysts Share Their Views ↗
 
Via Benzinga
News headline image
Looking Into Cencora's Recent Short Interest ↗
 
Via Benzinga
News headline image
Cencora Q1 Earnings: Revenue And EPS Beat On Strong Push From Obesity Drugs, Specialty Medicines ↗
Cencora posted Q1 sales of $81.5 billion, exceeding forecasts, with strong GLP-1 drug sales. Adjusted EPS beat estimates, and FY25 guidance was raised. 
Via Benzinga
News headline image
Cencora (NYSE:COR) Reports Upbeat Q4
Healthcare distributor Cencora (NYSE:COR) reported Q4 CY2024 results beating Wall Street’s revenue expectations, with sales up 12.8% year on year to $81.49 billion. Its non-GAAP profit of $3.73 per... 
Via StockStory
News headline image
Cencora Reports Fiscal 2025 First Quarter Results
From Cencora
Via Business Wire
News headline image
Jim Cramer: Lemonade Is 'Up Too Much,' This Health Care Stock Can Go Lower ↗
JMP Securities analyst Ronald Josey maintained Lemonade with a Market Outperform and raised the price target from $40 to $60. 
Via Benzinga
News headline image
Here's How Much You Would Have Made Owning Cencora Stock In The Last 10 Years ↗
 
Via Benzinga
News headline image
If You Invested $1000 In This Stock 10 Years Ago, You Would Have This Much Today ↗
 
Via Benzinga
News headline image
(COR) - Analyzing Cencora's Short Interest ↗
 
Via Benzinga
News headline image
$100 Invested In Cencora 5 Years Ago Would Be Worth This Much Today ↗
 
Via Benzinga
News headline image
Cencora Announces Date and Time for First Quarter Fiscal 2025 Earnings Release
From Cencora
Via Business Wire
News headline image
Cencora Completes Acquisition of Retina Consultants of America
From Cencora
Via Business Wire
News headline image
Cencora Closes $1.8 Billion Senior Notes Offering
From Cencora
Via Business Wire
News headline image
Cencora Prices $500 Million 4.625% Senior Notes Due 2027, $600 Million 4.850% Senior Notes Due 2029 and $700 Million 5.150% Senior Notes Due 2035
From Cencora
Via Business Wire
News headline image
Looking Into Cencora's Recent Short Interest ↗
 
Via Benzinga
News headline image
McKesson Stock Gets A RS Rating Lift To 75 ↗
The Relative Strength (RS) Rating for McKesson stock jumped into a new percentile Wednesday, as it got a lift from 70 to 75. 
Via Investor's Business Daily
News headline image
Cardinal Health Stock Sees IBD RS Rating Improve To 71 ↗
In a welcome move, Cardinal Health stock saw its Relative Strength (RS) Rating rise from 65 to 71 on Friday. 
Via Investor's Business Daily
News headline image
Deep Dive Into Cencora Stock: Analyst Perspectives (6 Ratings) ↗
 
Via Benzinga
News headline image
Trump's Win Sends Indices To Record Highs; Financials, Small Caps Surge, Bitcoin Tops $75,000: What's Driving Markets Wednesday? ↗
An “everything rally” powered Wall Street on Wednesday after the 2024 election results, with Donald Trump emerging as the clear presidential winner. 
Via Benzinga
Topics Government
News headline image
Cencora Acquires Retina Care Practice Network For $4.6 Billion, Boosts Dividend On Better Than Expected Q4 Earnings ↗
Cencora will potentially pay up to $500 million in aggregate contingent consideration in fiscal years 2027 and 2028. 
Via Benzinga
News headline image
If You Invested $100 In This Stock 5 Years Ago, You Would Have $300 Today ↗
 
Via Benzinga
News headline image
$1000 Invested In This Stock 5 Years Ago Would Be Worth $2,700 Today ↗
 
Via Benzinga
News headline image
Analyst Scoreboard: 6 Ratings For Cencora ↗
 
Via Benzinga
News headline image
Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
From Cencora
Via Business Wire
News headline image
Cencora Advances Specialty Leadership Through Acquisition of Retina Consultants of America
From Cencora
Via Business Wire
News headline image
Cencora Expands Enterprise Leadership Team with Two Senior Appointments
From Cencora
Via Business Wire
News headline image
Walgreens Stock Rally: 4 Reasons WBA Could Be a Strong Buy
Walgreens Boots Alliance (WBA) is down 60% from its 52-week high, but improving earnings, cost cuts, and a 9.27% dividend yield signal potential recovery. 
Via MarketBeat
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story